
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $4.2M | $6M | $10.1M | $12.9M | |
Revenue Growth (YoY) | -- | -- | 41.56% | 67.57% | 27.76% | |
Cost of Revenues | -- | $1.9M | $3.3M | $5.1M | $5M | |
Gross Profit | -- | $2.4M | $2.7M | $5M | $7.8M | |
Gross Profit Margin | -- | 55.83% | 45.38% | 49.81% | 60.96% | |
R&D Expenses | $5.9M | $9.6M | $13.1M | $22.2M | $14.4M | |
Selling, General & Admin | $11.8M | $46.6M | $55.9M | $33.8M | $30.5M | |
Other Inc / (Exp) | $991K | -$19.1M | $59.4M | $15.7M | -$62.2M | |
Operating Expenses | $22.4M | $71M | $93.6M | $74.4M | $57.6M | |
Operating Income | -$22.4M | -$68.6M | -$90.9M | -$69.4M | -$49.8M | |
Net Interest Expenses | -- | $8.8M | $555K | -- | $1.5M | |
EBT. Incl. Unusual Items | -$21.4M | -$96.5M | -$32.1M | -$51.9M | -$113.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $148K | -$232K | $4.6M | $9.1M | $2.9M | |
Net Income to Company | -$21.5M | -$96.3M | -$36.6M | -$61M | -$116.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$21.5M | -$96.3M | -$36.6M | -$61M | -$116.3M | |
Basic EPS (Cont. Ops) | -$0.31 | -$1.40 | -$0.44 | -$0.68 | -$1.28 | |
Diluted EPS (Cont. Ops) | -$0.31 | -$1.40 | -$0.66 | -$0.68 | -$1.28 | |
Weighted Average Basic Share | $68.8M | $68.8M | $83.2M | $89.5M | $91.2M | |
Weighted Average Diluted Share | $68.8M | $68.8M | $83.8M | $89.5M | $91.2M | |
EBITDA | -$18.3M | -$77.1M | -$16.1M | -$34.6M | -$100.7M | |
EBIT | -$21.3M | -$87.8M | -$30.5M | -$51.9M | -$113.3M | |
Revenue (Reported) | -- | $4.2M | $6M | $10.1M | $12.9M | |
Operating Income (Reported) | -$22.4M | -$68.6M | -$90.9M | -$69.4M | -$49.8M | |
Operating Income (Adjusted) | -$21.3M | -$87.8M | -$30.5M | -$51.9M | -$113.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $3.3M | $3.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | $1.3M | $1.2M | |
Gross Profit | -- | -- | -- | $2M | $2.2M | |
Gross Profit Margin | -- | -- | -- | 60.79% | 63.48% | |
R&D Expenses | -- | -- | -- | $4.4M | $2.5M | |
Selling, General & Admin | -- | -- | -- | $9.4M | $6.5M | |
Other Inc / (Exp) | -- | -- | -- | $649K | -$22.5M | |
Operating Expenses | -- | -- | -- | $16.6M | $11.7M | |
Operating Income | -- | -- | -- | -$14.6M | -$9.5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -$13.7M | -$31.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $1.4M | $715K | |
Net Income to Company | -- | -- | -- | -$15.2M | -$32.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -$15.2M | -$32.6M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -$0.17 | -$0.34 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.17 | -$0.34 | |
Weighted Average Basic Share | -- | -- | -- | $90.3M | $96.7M | |
Weighted Average Diluted Share | -- | -- | -- | $90.3M | $96.7M | |
EBITDA | -- | -- | -- | -$11.8M | -$6.8M | |
EBIT | -- | -- | -- | -$14.6M | -$9.5M | |
Revenue (Reported) | -- | -- | -- | $3.3M | $3.4M | |
Operating Income (Reported) | -- | -- | -- | -$14.6M | -$9.5M | |
Operating Income (Adjusted) | -- | -- | -- | -$14.6M | -$9.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | $649K | -$25.3M | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $3.3M | $3.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | $1.3M | $1.2M | |
Gross Profit | -- | -- | -- | $2M | $2.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | $4.4M | $2.5M | |
Selling, General & Admin | -- | -- | -- | $9.4M | $6.5M | |
Other Inc / (Exp) | -- | -- | -- | $649K | -$22.5M | |
Operating Expenses | -- | -- | -- | $16.6M | $11.7M | |
Operating Income | -- | -- | -- | -$14.6M | -$9.5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -$13.7M | -$31.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $1.4M | $715K | |
Net Income to Company | -- | -- | -- | -$15.2M | -$32.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -$15.2M | -$32.6M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -$0.17 | -$0.34 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.17 | -$0.34 | |
Weighted Average Basic Share | -- | -- | -- | $90.3M | $96.7M | |
Weighted Average Diluted Share | -- | -- | -- | $90.3M | $96.7M | |
EBITDA | -- | -- | -- | -$11.8M | -$6.8M | |
EBIT | -- | -- | -- | -$14.6M | -$9.5M | |
Revenue (Reported) | -- | -- | -- | $3.3M | $3.4M | |
Operating Income (Reported) | -- | -- | -- | -$14.6M | -$9.5M | |
Operating Income (Adjusted) | -- | -- | -- | -$14.6M | -$9.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $17.3M | $8.5M | $76.5M | $23.5M | $22.5M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $4K | $1.2M | $1.4M | $901K | $1.5M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $669K | $2M | $2.4M | $1.9M | $3M | |
Other Current Assets | $103K | $713K | $843K | $239K | $877K | |
Total Current Assets | $18M | $12.4M | $81.2M | $26.6M | $27.9M | |
Property Plant And Equipment | $36.2M | $35.5M | $56.2M | $44.3M | $28.1M | |
Long-Term Investments | $314K | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | $369K | $6.5M | $5.5M | $5.7M | |
Total Assets | $54.6M | $49.9M | $143.9M | $76.4M | $61.7M | |
Accounts Payable | $2.9M | $6.7M | $9.9M | $7.9M | $3.8M | |
Accrued Expenses | -- | $23.4M | $6.4M | $4.4M | $11.6M | |
Current Portion Of Long-Term Debt | $125.1M | $108.5M | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $362K | $985K | $2.2M | $2.1M | $363K | |
Other Current Liabilities | -$36K | $143.2M | $9.7M | $3.2M | $13M | |
Total Current Liabilities | $131.3M | $283.7M | $30.1M | $21.4M | $34.6M | |
Long-Term Debt | $33.8M | -- | -- | -- | $79.1M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $171.9M | $289.4M | $37.7M | $24.7M | $114.7M | |
Common Stock | -- | $21.3M | -- | -- | -- | |
Other Common Equity Adj | -- | -$86K | -$312K | -$33K | -$571K | |
Common Equity | -$117.3M | -$260.7M | $106.2M | $51.7M | -$53M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$117.3M | -$239.4M | $106.2M | $51.7M | -$53M | |
Total Liabilities and Equity | $54.6M | $49.9M | $143.9M | $76.4M | $61.7M | |
Cash and Short Terms | $17.3M | $8.5M | $76.5M | $23.5M | $22.5M | |
Total Debt | -- | $108.5M | -- | -- | $79.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | -- | $17.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | $1.8M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | $2.2M | |
Other Current Assets | -- | -- | -- | -- | $1M | |
Total Current Assets | -- | -- | -- | -- | $24.1M | |
Property Plant And Equipment | -- | -- | -- | -- | $32.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | $5M | |
Total Assets | -- | -- | -- | -- | $61.4M | |
Accounts Payable | -- | -- | -- | -- | $3.7M | |
Accrued Expenses | -- | -- | -- | -- | $13.7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $989K | |
Other Current Liabilities | -- | -- | -- | -- | $16.9M | |
Total Current Liabilities | -- | -- | -- | -- | $41.6M | |
Long-Term Debt | -- | -- | -- | -- | $96.6M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | -- | $144.5M | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -$314K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -- | -- | -$83.1M | |
Total Liabilities and Equity | -- | -- | -- | -- | $61.4M | |
Cash and Short Terms | -- | -- | -- | -- | $17.7M | |
Total Debt | -- | -- | -- | -- | $96.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$21.5M | -$96.3M | -$36.6M | -$61M | -$116.3M | |
Depreciation & Amoritzation | $3M | $10.7M | $14.3M | $17.3M | $12.7M | |
Stock-Based Compensation | $1.7M | $10.9M | $8.4M | $6.3M | $2.3M | |
Change in Accounts Receivable | -$221K | -$4.7M | -$1.9M | -$385K | -$1.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$11.2M | -$28.4M | -$68.5M | -$49.6M | -$35.9M | |
Capital Expenditures | -- | $11.2M | $27.3M | $14.9M | $5M | |
Cash Acquisitions | -- | -- | -$3.7M | -- | -- | |
Cash From Investing | -$15.8M | -$11.2M | -$30.9M | -$14.4M | -$5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $17.3M | $7.5M | -- | -- | $30M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -$8.6M | -- | -- | |
Other Financing Activities | -- | -- | -- | -$458K | -$3.1M | |
Cash From Financing | $18.2M | $28.6M | $164.3M | -$83K | $37.5M | |
Beginning Cash (CF) | $24.6M | $17.3M | $8.5M | $77.8M | $24.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$8.8M | -$11M | $65M | -$64.1M | -$3.5M | |
Ending Cash (CF) | $17.3M | $8.5M | $77.8M | $24.6M | $23.7M | |
Levered Free Cash Flow | -$27M | -$39.7M | -$95.7M | -$64.5M | -$40.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$15.2M | -$32.6M | |
Depreciation & Amoritzation | -- | -- | -- | $2.8M | $2.7M | |
Stock-Based Compensation | -- | -- | -- | $1.4M | $595K | |
Change in Accounts Receivable | -- | -- | -- | -$932K | -$21K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -$10.1M | -$4.7M | |
Capital Expenditures | -- | -- | -- | $1.9M | $1.9M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -$1.9M | -$1.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -$184K | -$375K | |
Cash From Financing | -- | -- | -- | -$184K | $1.7M | |
Beginning Cash (CF) | -- | -- | -- | $24.6M | $23.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | $542K | $177K | |
Additions / Reductions | -- | -- | -- | -$12.2M | -$5M | |
Ending Cash (CF) | -- | -- | -- | $12.9M | $18.9M | |
Levered Free Cash Flow | -- | -- | -- | -$12.1M | -$6.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | $1.4M | $1.9M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | $1.9M | $5.2M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$15.2M | -$32.6M | |
Depreciation & Amoritzation | -- | -- | -- | $2.8M | $2.7M | |
Stock-Based Compensation | -- | -- | -- | $1.4M | $595K | |
Change in Accounts Receivable | -- | -- | -- | -$932K | -$21K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -$10.1M | -$4.7M | |
Capital Expenditures | -- | -- | -- | $1.9M | $1.9M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -$1.9M | -$1.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -$184K | -$375K | |
Cash From Financing | -- | -- | -- | -$184K | $1.7M | |
Beginning Cash (CF) | -- | -- | -- | $24.6M | $23.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | $542K | $177K | |
Additions / Reductions | -- | -- | -- | -$12.2M | -$5M | |
Ending Cash (CF) | -- | -- | -- | $12.9M | $18.9M | |
Levered Free Cash Flow | -- | -- | -- | -$12.1M | -$6.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.